SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending its stock price plummeting by more than 20%. The reason for the breakdown of the partnership remains unclear, but get more info industry analysts speculate th